ES2166375T3 - Composicion acuosa. - Google Patents

Composicion acuosa.

Info

Publication number
ES2166375T3
ES2166375T3 ES94921811T ES94921811T ES2166375T3 ES 2166375 T3 ES2166375 T3 ES 2166375T3 ES 94921811 T ES94921811 T ES 94921811T ES 94921811 T ES94921811 T ES 94921811T ES 2166375 T3 ES2166375 T3 ES 2166375T3
Authority
ES
Spain
Prior art keywords
pct
sec
date
water
pub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921811T
Other languages
English (en)
Inventor
Yuzo Kimura
Shinichi Ishikawa
Yoshito Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2166375T3 publication Critical patent/ES2166375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

LA INVENCION PROPORCIONA UNA COMPOSICION EN DONDE UN COMPUESTO ACTIVO A PENAS SOLUBLE EN AGUA, 6-[3-(3,4-DIMETOXIBENCIL)AMINO-2HIDROXIPROPOXI]CARBOESTIRILO O UNA SAL DEL MISMO SE DISUELVE EN AGUA EN UNA CANTIDAD EFECTIVA, PARTICULARMENTE EN UNA CANTIDAD SUFICIENTE PARA MOSTRAR LAS ACTIVIDADES FARMACEUTICAS, USANDO COMO SOLUBILIZADOR ACIDO DL-LACTICO.
ES94921811T 1993-07-28 1994-07-25 Composicion acuosa. Expired - Lifetime ES2166375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18597393 1993-07-28

Publications (1)

Publication Number Publication Date
ES2166375T3 true ES2166375T3 (es) 2002-04-16

Family

ID=16180120

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921811T Expired - Lifetime ES2166375T3 (es) 1993-07-28 1994-07-25 Composicion acuosa.

Country Status (15)

Country Link
US (1) US5686440A (es)
EP (1) EP0662833B1 (es)
KR (1) KR0178308B1 (es)
CN (1) CN1060041C (es)
AT (1) ATE207358T1 (es)
AU (1) AU669451B2 (es)
CA (1) CA2144729A1 (es)
DE (1) DE69428771T2 (es)
DK (1) DK0662833T3 (es)
ES (1) ES2166375T3 (es)
GR (1) GR3037007T3 (es)
PH (1) PH31591A (es)
PT (1) PT662833E (es)
TW (1) TW254855B (es)
WO (1) WO1995003802A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129350A (en) * 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164570A (en) * 1973-09-24 1979-08-14 David Clough Stabilized aqueous catecholamine solutions
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE68920797T2 (de) * 1988-08-10 1995-06-29 Otsuka Pharma Co Ltd Herzmittel.

Also Published As

Publication number Publication date
DK0662833T3 (da) 2001-12-03
GR3037007T3 (en) 2002-01-31
WO1995003802A1 (en) 1995-02-09
US5686440A (en) 1997-11-11
CN1113074A (zh) 1995-12-06
DE69428771T2 (de) 2002-05-08
TW254855B (es) 1995-08-21
AU7237894A (en) 1995-02-28
EP0662833B1 (en) 2001-10-24
KR0178308B1 (ko) 1999-03-20
ATE207358T1 (de) 2001-11-15
DE69428771D1 (de) 2001-11-29
PT662833E (pt) 2002-02-28
CN1060041C (zh) 2001-01-03
AU669451B2 (en) 1996-06-06
CA2144729A1 (en) 1995-02-09
PH31591A (en) 1998-11-03
EP0662833A1 (en) 1995-07-19
KR950703342A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
BR9609888A (pt) Halogenobenzimidazóis
DE69408666D1 (de) Risperidon pamoate
BR9606547A (pt) Novos derivados de pirimidona com atividade fungicida
PT771197E (pt) Utilizacao de compostos heterociclicos como ligantes de dopamina-d 3
DE69225970T2 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
BR9405910A (pt) Piridinas substituídas heterocíclicas herbicidas
DE69413019T2 (de) Stickstoff enthaltende kondensierte heterocylen
ATE186624T1 (de) Spraydesinfektionsmittelzubereitung
DE69516115D1 (de) Schmiermittelzusammensetzungen
DK0656015T3 (da) Nye inklusionskomplekser af nimesulidsalt med cyclodextrin
FI962261A (fi) N-bis- tai N-tris-((1,2-dikarboksyyli-etoksi)-etyyli)amiinijohdannaiset, niiden valmistus ja käyttö
ES2166375T3 (es) Composicion acuosa.
ES2038207T3 (es) Procedimiento para la obtencion de 2-piridil-penem-compuestos.
ATE238299T1 (de) N-sulfonylimidazole als fungizide
CA2211681A1 (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
DK0639049T3 (da) Halogenerede 4'-methoxyacetophenoner som mikrobicider og konserveringsmidler
SE9202434D0 (sv) Skatolinaktiverande komposition
KR880013453A (ko) 제초제 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 662833

Country of ref document: ES